Dr Flanigan discusses a new knee device designed to treat osteoarthritis symptoms, how it could potentially help patients prevent or delay knee replacements, and more.
Dr Loo and Dr Chen highlight the current management of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, obesity as a risk factor for the diseases, and more.
Dr Edgerton discusses the prevalence of arthritis among active and former service members, the importance of a dedicated arthritis research program at the United States Department of Defense, and more.
...
In this podcast, Laurence Sperling, MD, from Emory University School of Medicine, explains the newest ACC/AHA cholesterol guidelines, the top 10 take-home messages for cardiologists, and the lessons learned...
Dr Merrill discusses her research that evaluated different serologic features to encourage more entry in lupus clinical trials of individuals with active disease, and more.
Dr Spergel discusses the current management of milk-induced eosinophilic esophagitis among children and his study that evaluated epicutaneous immunotherapy as a potential treatment option.
In this podcast, Shane Liddelow, PhD, from NYU Langone Health, discusses his latest research on astrocytes—a topic he also spoke about at the Alzheimer's Association International Conference 2019.
Alessio Fasano, MD, discusses the need for more novel tools to perform better research on celiac disease, his research on a new 3-dimensional model for studying the effect of microbiota-derived...
Nancy Desai, MD, discusses her research that explored the association between lupus, cervical cancer screening, and prevention, as well as why providers should educate patients on their risk of cervical...
In this podcast, Peter Reaven, MD, discusses the effects of glucose variability on vascular disease outcomes, the results of the ACCORD and VADT trials, and how the trials' results have impacted clinical...
